Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Apellis Pharmaceuticals Inc
(NQ:
APLS
)
40.11
+0.97 (+2.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apellis Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Catalent (CTLT) Stock Gains on Elliott Deal
August 29, 2023
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.
Via
InvestorPlace
Apellis Layoffs 2023: What to Know About the Latest APLS Job Cuts
August 29, 2023
Apellis Pharmaceuticals (APLS) layoffs are a hot topic on Tuesday as the commercial-stage biopharmaceutical company prepares for job cuts.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Apellis Announces Corporate Restructuring to Drive Growth of SYFOVRE® (pegcetacoplan injection) and EMPAVELI® (pegcetacoplan), Positioning Company for Long-Term Success
August 29, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apellis Pharmaceuticals, Inc.
August 29, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Where Apellis Pharmaceuticals Stands With Analysts
August 24, 2023
Via
Benzinga
Apellis Pharmaceuticals Inc. (NASDAQ: APLS) Near the Top of Equities by Percentage Gain on 8/23
August 23, 2023
Via
Investor Brand Network
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS
August 28, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eos, Apellis, and Party City and Encourages Investors to Contact the Firm
August 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS
August 27, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS
August 26, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 25, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
APLS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Apellis Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Apellis Class Action Lawsuit
August 24, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
3 Very Oversold Pharma Stocks to Buy Right Now
August 24, 2023
Oversold pharma stocks have great total return potential. In this article, we list some of the best to buy.
Via
InvestorPlace
Apellis Pharma's Newly Launched Eye Drug Set For Resilient Performance, Syfovre Update Sparks Optimism
August 23, 2023
HC Wainwright says the relative lack of new cases is a positive and should jumpstart Apellis Pharmaceuticals Inc (NASDAQ: APLS) Syfovre,
Via
Benzinga
S&P 500 Gains 1%; Analog Devices Posts Downbeat Results
August 23, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Wednesday. The Dow traded up 0.51% to 34,462.61 while the NASDAQ rose 1.60% to 13,722.24....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 23, 2023
Via
Benzinga
Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 23, 2023
Gainers AgileThought, Inc. (NASDAQ: AGIL) jumped 85.5% to $0.3941. AgileThought recently posted a loss for the second quarter.
Via
Benzinga
Crude Oil Edges Lower; VCI Global Shares Spike Higher
August 23, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. The Dow traded up 0.40% to 34,425.29 while the NASDAQ rose 1.40% to 13,694.79. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories
August 23, 2023
Wall Street Journal Airbnb Versus New York: What's Going On?
Via
Benzinga
Apellis Soars 28% After Identifying Potential Culprit Behind Eye Drug Safety Woes
August 23, 2023
Apellis has been investigating cases of eye inflammation following treatment with Syfovre.
Via
Investor's Business Daily
Why Is Apellis Pharmaceuticals Stock Shooting Higher Today?
August 23, 2023
Apellis Pharmaceuticals Inc (NASDAQ: APLS) released a comprehensive update regarding its Syfovre (pegcetacoplan injection) treatment for geographic atrophy (GA) secondary to age-
Via
Benzinga
DKS Stock Alert: Dick’s Sporting Goods Continues to Drop After Worst Day on Record
August 23, 2023
Dick's Sporting Goods (DKS) stock continues to see negative movement on Wednesday after experiencing a horrible fall on Tuesday.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 23, 2023
Via
Benzinga
Why Is Foot Locker (FL) Stock Down 31% Today?
August 23, 2023
Foot Locker (FL) stock is taking a beating on Wednesday after the athletic wear retailer released its Q2 earnings report.
Via
InvestorPlace
Why Is AMC Entertainment (AMC) Stock Down 20% Today?
August 23, 2023
AMC Entertainment (AMC) stock is falling on Wednesday as the movie theater company prepares for a stock conversion on Friday.
Via
InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
August 23, 2023
Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
Via
Benzinga
Why Is Apellis Pharmaceuticals (APLS) Stock Up 23% Today?
August 23, 2023
Apellis Pharmaceuticals (APLS) stock is on the rise Wednesday after the biopharmaceutical company announced an update on injection kits.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 23, 2023
It's time for another dive into the biggest pre-market stock movers as we break down all of the biggest news on Wednesday!
Via
InvestorPlace
Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
August 23, 2023
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 22, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.